EZH2 and diffuse large B-cell lymphoma: Missense mutations in GCB-DLBCL are frequently represented by GOF mutations in the EZH2 SET domain [44,45] that enhance PRC2 methyltransferase activity, leading to an abnormally high level of the chromatin repressive H3K27me3 mark [46,47].